Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pomerantz Roger | Director | 33 | $0 | $0 | 2024-11-25 |
| ROYSTON IVOR | Director | 38 | $44.5K | $252.8K | 2024-11-25 |
| Chung Jane | Director | 3 | $0 | $0 | 2024-06-20 |
| Borellini Flavia | Director | 4 | $0 | $0 | 2024-06-20 |
| Rubino Stephen | Director | 4 | $0 | $0 | 2024-06-20 |
| Murphy Samuel Lafayette | Director | 4 | $0 | $0 | 2024-06-20 |
| Barlow Jane F | Director | 4 | $0 | $0 | 2024-06-20 |
| Simon Barry J. | Director | 4 | $0 | $0 | 2024-06-20 |
| DARCY THOMAS E | Director | 4 | $0 | $0 | 2024-06-20 |
| Faerm Michael E. | Chief Financial Officer | 1 | $0 | $0 | 2024-05-14 |
| Cohen Darrel P. | Chief Medical Officer | 3 | $0 | $0 | 2024-03-12 |
| Chevallard Daniel R. | CFO and COO | 39 | $0 | $99.4K | 2024-03-12 |
| Rothera Mark | President and CEO | 5 | $49.0K | $0 | 2024-03-12 |
| Rojkjaer Lisa | Chief Medical Officer | 26 | $0 | $50.8K | 2023-03-16 |
| Huang Michael | Director | 2 | $0 | $0 | 2022-06-09 |
| ONETTO NICOLE | Director | 2 | $0 | $0 | 2022-06-09 |
| Roshwalb Gur | Director, 10% Owner | 1 | $0 | $0 | 2021-03-26 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pomerantz Roger | Director | M Exercise deriv | 2024-11-25 | 2024-11-27 | 9,034 | — | $0 | 18,069 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2024-11-25 | 2024-11-27 | 25,219 | — | $0 | 50,438 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2024-11-25 | 2024-11-27 | 9,034 | — | $0 | 126,478 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2024-11-25 | 2024-11-27 | 25,219 | — | $0 | 839,741 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2024-08-25 | 2024-09-12 | 9,034 | — | $0 | 27,103 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2024-08-25 | 2024-09-12 | 25,219 | — | $0 | 75,657 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2024-08-25 | 2024-09-12 | 9,034 | — | $0 | 117,444 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2024-08-25 | 2024-09-12 | 25,219 | — | $0 | 814,522 | SEC↗ |
| Rubino Stephen | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Barlow Jane F | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Murphy Samuel Lafayette | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Chung Jane | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Borellini Flavia | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ROYSTON IVOR | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2024-05-25 | 2024-05-29 | 25,219 | — | $0 | 100,876 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2024-05-25 | 2024-05-29 | 9,035 | — | $0 | 36,137 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2024-05-25 | 2024-05-29 | 25,219 | — | $0 | 789,303 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2024-05-25 | 2024-05-29 | 9,035 | — | $0 | 108,410 | SEC↗ |
| Faerm Michael E. | Chief Financial Officer | A Award deriv | 2024-05-14 | 2024-05-16 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | A Award deriv | 2024-03-12 | 2024-03-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Cohen Darrel P. | Chief Medical Officer | A Award deriv | 2024-03-12 | 2024-03-13 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Rothera Mark | President and CEO | A Award deriv | 2024-03-12 | 2024-03-13 | 475,000 | — | $0 | 475,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2024-02-27 | 2024-02-27 | 3,405 | $0.73 | $2.5K | 102,306 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2024-02-25 | 2024-02-27 | 6,889 | — | $0 | 34,444 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2024-02-25 | 2024-02-27 | 9,034 | — | $0 | 45,172 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2024-02-25 | 2024-02-27 | 25,219 | — | $0 | 126,095 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2024-02-25 | 2024-02-27 | 6,889 | — | $0 | 105,711 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2024-02-25 | 2024-02-27 | 9,034 | — | $0 | 99,375 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2024-02-25 | 2024-02-27 | 25,219 | — | $0 | 764,084 | SEC↗ |
| Rothera Mark | President and CEO | P Buy | 2023-12-01 | 2023-12-04 | 47,906 | $0.49 | $23.5K | 100,000 | SEC↗ |
| Rothera Mark | President and CEO | P Buy | 2023-11-30 | 2023-12-04 | 52,094 | $0.49 | $25.5K | 52,094 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2023-11-28 | 2023-11-28 | 3,720 | $0.50 | $1.9K | 98,822 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2023-11-25 | 2023-11-28 | 9,034 | — | $0 | 54,206 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2023-11-25 | 2023-11-28 | 25,219 | — | $0 | 151,314 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2023-11-25 | 2023-11-28 | 6,889 | — | $0 | 41,333 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2023-11-25 | 2023-11-28 | 9,034 | — | $0 | 90,341 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2023-11-25 | 2023-11-28 | 25,219 | — | $0 | 738,865 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2023-11-25 | 2023-11-28 | 6,889 | — | $0 | 102,542 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2023-08-28 | 2023-08-29 | 3,512 | $1.45 | $5.1K | 95,653 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2023-08-25 | 2023-08-29 | 6,888 | — | $0 | 48,222 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2023-08-25 | 2023-08-29 | 9,034 | — | $0 | 63,240 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2023-08-25 | 2023-08-29 | 25,219 | — | $0 | 176,533 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2023-08-25 | 2023-08-29 | 6,888 | — | $0 | 99,165 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2023-08-25 | 2023-08-29 | 9,034 | — | $0 | 81,307 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2023-08-25 | 2023-08-29 | 25,219 | — | $0 | 713,646 | SEC↗ |
| Cohen Darrel P. | Chief Medical Officer | A Award deriv | 2023-08-16 | 2023-08-18 | 265,000 | — | $0 | 265,000 | SEC↗ |
| Cohen Darrel P. | Chief Medical Officer | A Award deriv | 2023-08-16 | 2023-08-18 | 235,000 | — | $0 | 235,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2023-08-16 | 2023-08-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Barlow Jane F | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Borellini Flavia | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chung Jane | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Murphy Samuel Lafayette | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ROYSTON IVOR | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rubino Stephen | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2023-05-25 | 2023-05-26 | 6,889 | — | $0 | 55,110 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2023-05-25 | 2023-05-26 | 9,035 | — | $0 | 72,274 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2023-05-25 | 2023-05-26 | 25,219 | — | $0 | 201,752 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2023-05-25 | 2023-05-26 | 3,635 | $1.42 | $5.2K | 92,277 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2023-05-25 | 2023-05-26 | 6,889 | — | $0 | 95,912 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2023-05-25 | 2023-05-26 | 9,035 | — | $0 | 72,273 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2023-05-25 | 2023-05-26 | 25,219 | — | $0 | 688,427 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | A Award deriv | 2023-03-16 | 2023-03-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | A Award deriv | 2023-03-16 | 2023-03-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Rothera Mark | President and CEO | A Award deriv | 2023-03-16 | 2023-03-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2023-02-27 | 2023-02-28 | 3,599 | $1.68 | $6.0K | 89,023 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2023-02-27 | 2023-02-28 | 2,156 | $1.68 | $3.6K | 48,087 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2023-02-25 | 2023-02-28 | 6,889 | — | $0 | 61,999 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2023-02-25 | 2023-02-28 | 9,034 | — | $0 | 81,309 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2023-02-25 | 2023-02-28 | 4,127 | — | $0 | 37,146 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2023-02-25 | 2023-02-28 | 25,219 | — | $0 | 226,971 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2023-02-25 | 2023-02-28 | 6,889 | — | $0 | 92,622 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2023-02-25 | 2023-02-28 | 9,034 | — | $0 | 63,238 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2023-02-25 | 2023-02-28 | 4,127 | — | $0 | 50,243 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2023-02-25 | 2023-02-28 | 25,219 | — | $0 | 663,208 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2022-11-28 | 2022-11-29 | 2,116 | $2.72 | $5.8K | 46,116 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2022-11-28 | 2022-11-29 | 3,532 | $2.72 | $9.6K | 85,733 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise deriv | 2022-11-25 | 2022-11-29 | 25,219 | — | $0 | 252,190 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2022-11-25 | 2022-11-29 | 9,034 | — | $0 | 90,343 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2022-11-25 | 2022-11-29 | 4,127 | — | $0 | 41,273 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2022-11-25 | 2022-11-29 | 6,889 | — | $0 | 68,888 | SEC↗ |
| ROYSTON IVOR | Director | M Exercise | 2022-11-25 | 2022-11-29 | 25,219 | — | $0 | 637,989 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2022-11-25 | 2022-11-29 | 9,034 | — | $0 | 54,204 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2022-11-25 | 2022-11-29 | 4,127 | — | $0 | 48,232 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2022-11-25 | 2022-11-29 | 6,889 | — | $0 | 89,265 | SEC↗ |
| Rothera Mark | President and CEO | A Award deriv | 2022-09-19 | 2022-09-19 | 1,375,000 | — | $0 | 1,375,000 | SEC↗ |
| ROYSTON IVOR | CEO & President | S Sale | 2022-08-26 | 2022-08-29 | 13,379 | $4.01 | $53.6K | 612,770 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2022-08-26 | 2022-08-29 | 3,655 | $4.02 | $14.7K | 82,376 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2022-08-26 | 2022-08-29 | 2,190 | $4.01 | $8.8K | 44,105 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise deriv | 2022-08-25 | 2022-08-29 | 25,219 | — | $0 | 277,409 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2022-08-25 | 2022-08-29 | 6,889 | — | $0 | 75,777 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2022-08-25 | 2022-08-29 | 9,034 | — | $0 | 99,377 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2022-08-25 | 2022-08-29 | 4,127 | — | $0 | 45,400 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise | 2022-08-25 | 2022-08-29 | 25,219 | — | $0 | 626,149 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2022-08-25 | 2022-08-29 | 6,889 | — | $0 | 86,031 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2022-08-25 | 2022-08-29 | 9,034 | — | $0 | 45,170 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2022-08-25 | 2022-08-29 | 4,127 | — | $0 | 46,295 | SEC↗ |
| Chung Jane | Director | A Award deriv | 2022-08-10 | 2022-08-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2022-08-10 | 2022-08-11 | 30,282 | — | $0 | 30,282 | SEC↗ |
| Barlow Jane F | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Borellini Flavia | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Huang Michael | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Murphy Samuel Lafayette | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ONETTO NICOLE | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rubino Stephen | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2022-05-26 | 2022-05-27 | 3,596 | $1.90 | $6.8K | 79,142 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2022-05-26 | 2022-05-27 | 2,154 | $1.90 | $4.1K | 42,168 | SEC↗ |
| ROYSTON IVOR | CEO & President | S Sale | 2022-05-26 | 2022-05-27 | 13,162 | $1.90 | $25.0K | 600,930 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2022-05-25 | 2022-05-27 | 6,889 | — | $0 | 82,666 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2022-05-25 | 2022-05-27 | 9,034 | — | $0 | 108,411 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2022-05-25 | 2022-05-27 | 4,127 | — | $0 | 49,527 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise deriv | 2022-05-25 | 2022-05-27 | 25,219 | — | $0 | 302,628 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2022-05-25 | 2022-05-27 | 6,889 | — | $0 | 82,738 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2022-05-25 | 2022-05-27 | 9,034 | — | $0 | 36,136 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2022-05-25 | 2022-05-27 | 4,127 | — | $0 | 44,322 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise | 2022-05-25 | 2022-05-27 | 25,219 | — | $0 | 614,092 | SEC↗ |
| ROYSTON IVOR | CEO & President | A Award deriv | 2022-03-17 | 2022-03-18 | 412,500 | — | $0 | 412,500 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | A Award deriv | 2022-03-17 | 2022-03-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | A Award deriv | 2022-03-17 | 2022-03-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | S Sale | 2022-02-28 | 2022-03-01 | 3,998 | $2.78 | $11.1K | 75,849 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2022-02-28 | 2022-03-01 | 2,395 | $2.78 | $6.7K | 40,195 | SEC↗ |
| ROYSTON IVOR | CEO & President | S Sale | 2022-02-28 | 2022-03-01 | 14,635 | $2.78 | $40.7K | 588,873 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2022-02-25 | 2022-03-01 | 6,889 | — | $0 | 89,555 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2022-02-25 | 2022-03-01 | 9,034 | — | $0 | 117,445 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2022-02-25 | 2022-03-01 | 4,127 | — | $0 | 53,654 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise deriv | 2022-02-25 | 2022-03-01 | 25,219 | — | $0 | 327,847 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2022-02-25 | 2022-03-01 | 6,889 | — | $0 | 79,847 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2022-02-25 | 2022-03-01 | 9,034 | — | $0 | 27,102 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2022-02-25 | 2022-03-01 | 4,127 | — | $0 | 42,590 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise | 2022-02-25 | 2022-03-01 | 25,219 | — | $0 | 603,508 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise deriv | 2021-12-29 | 2021-12-30 | 7,000 | — | $0 | 60,800 | SEC↗ |
| ROYSTON IVOR | CEO & President | M Exercise | 2021-12-29 | 2021-12-30 | 7,000 | $0.90 | $6.3K | 578,289 | SEC↗ |
| CEO & President | S Sale | 2021-11-29 | 2021-11-29 | 15,833 | $4.82 | $76.3K | 571,289 | SEC↗ | |
| CFO and COO | S Sale | 2021-11-29 | 2021-11-29 | 4,325 | $4.82 | $20.8K | 72,958 | SEC↗ | |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2021-11-29 | 2021-11-29 | 2,591 | $4.82 | $12.5K | 38,463 | SEC↗ |
| CEO & President | S Sale | 2021-11-26 | 2021-11-29 | 11,914 | $4.80 | $57.2K | 587,122 | SEC↗ | |
| CFO and COO | S Sale | 2021-11-26 | 2021-11-29 | 3,254 | $4.80 | $15.6K | 77,283 | SEC↗ | |
| Rojkjaer Lisa | Chief Medical Officer | S Sale | 2021-11-26 | 2021-11-29 | 1,950 | $4.80 | $9.4K | 41,054 | SEC↗ |
| CEO & President | M Exercise deriv | 2021-11-25 | 2021-11-29 | 50,437 | — | $0 | 353,066 | SEC↗ | |
| CFO and COO | M Exercise deriv | 2021-11-25 | 2021-11-29 | 13,777 | — | $0 | 96,444 | SEC↗ | |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2021-11-25 | 2021-11-29 | 8,254 | — | $0 | 57,781 | SEC↗ |
| Pomerantz Roger | Director | M Exercise deriv | 2021-11-25 | 2021-11-29 | 18,068 | — | $0 | 126,479 | SEC↗ |
| CEO & President | M Exercise | 2021-11-25 | 2021-11-29 | 50,437 | — | $0 | 599,036 | SEC↗ | |
| CFO and COO | M Exercise | 2021-11-25 | 2021-11-29 | 13,777 | — | $0 | 80,537 | SEC↗ | |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2021-11-25 | 2021-11-29 | 8,254 | — | $0 | 43,004 | SEC↗ |
| Pomerantz Roger | Director | M Exercise | 2021-11-25 | 2021-11-29 | 18,068 | — | $0 | 18,068 | SEC↗ |
| ROYSTON IVOR | CEO & President | P Buy | 2021-11-15 | 2021-11-15 | 8,000 | $5.56 | $44.5K | 548,599 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2021-09-28 | 2021-09-29 | 10,000 | — | $0 | 88,817 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2021-09-28 | 2021-09-29 | 10,000 | $0.90 | $9.0K | 66,760 | SEC↗ |
| Barlow Jane F | Director | A Award deriv | 2021-08-16 | 2021-08-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Borellini Flavia | Director | A Award deriv | 2021-08-16 | 2021-08-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise deriv | 2021-05-28 | 2021-06-01 | 12,000 | — | $0 | 98,817 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | M Exercise | 2021-05-28 | 2021-06-01 | 12,000 | $0.90 | $10.8K | 56,760 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2021-05-11 | 2021-05-13 | 32,689 | — | $0 | 98,069 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise deriv | 2021-05-11 | 2021-05-13 | 2,061 | — | $0 | 30,956 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2021-05-11 | 2021-05-13 | 32,689 | $1.26 | $41.2K | 32,689 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | M Exercise | 2021-05-11 | 2021-05-13 | 2,061 | $3.58 | $7.4K | 34,750 | SEC↗ |
| Chevallard Daniel R. | CFO and COO | A Award deriv | 2021-03-26 | 2021-03-30 | 78,912 | — | $0 | 78,912 | SEC↗ |
| ROYSTON IVOR | CEO & President | A Award deriv | 2021-03-26 | 2021-03-30 | 441,993 | — | $0 | 441,993 | SEC↗ |
| Rubino Stephen | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Murphy Samuel Lafayette | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Roshwalb Gur | Director, 10% Owner | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Huang Michael | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ONETTO NICOLE | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Rojkjaer Lisa | Chief Medical Officer | A Award deriv | 2021-03-26 | 2021-03-30 | 126,890 | — | $0 | 126,890 | SEC↗ |